Collection
MeSH Terms
carcinoma, non-small-cell lung, adenocarcinoma, bronchioloalveolar, lung, ErbB Receptors, HER2, HER-2, HER2-positive, HER2- overexpressing, HER2 gene amplification, Anaplastic Lymphoma Kinase, Receptor Protein-Tyrosine Kinases, Receptor, trkC, Proto-Oncogene Proteins, ROS1, ROS-1, Proto-Oncogene Proteins c-ret, Proto-Oncogene Proteins c-met, Phosphatidylinositol 3-Kinase, Genes, erbB-2, Quinazolines, Piperidines, Aminopyridines, Sulfones, Protein Kinase Inhibitors, Carbazoles, Lactams, Macrocyclic, Imidazoles, Pyrimidines, radiotherapy
Keywords
carcinoma, non-small-cell lung, adenocarcinoma, bronchioloalveolar, lung, radiotherapy
Date for Review
In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Record Publish Year
2021
Publication Date
2021-02-16
Date of Last Evidence Search
2020-02-04
Methods Applied
Systematic review-based, Externally reviewed; Evidence quality assessment
Guideline Contact
Emily Vella; pebconc@mcmaster.ca
Publication Scope
Guidelines
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
ASCO (US)
PEBC (Program in evidenced-based care)
Publication Year
2021